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Abstract
Background: Using a longitudinal design, aim of this study was to investigate the relation between mental
adjustment to cancer and anxiety, depression, health-related quality of life (HRQL) and survival in patients treated
for laryngeal cancer.
Methods: 95 patients with Tis-T4 laryngeal cancer were assessed at one and 12 months after start of treatment,
respectively, using the Mini-Mental Adjustment to Cancer Scale (Mini-MAC), the European Organisation for Research
and Treatment of Cancer (EORTC) Study Group on Quality of Life core questionnaire (EORTC QLQ-C30)
supplemented with the Head and Neck cancer module (QLQ-H&N35) and the Hospital Anxiety and Depression
(HAD) Scale. For survival analyses patients were followed up for a median time of 4.22 years from inclusion.
Results: The most commonly used adjustment response at both occasions was Fighting Spirit. The use of
adjustment responses was relatively stable over time. Correlation analyses showed that patients using Helpless-
Hopeless and Anxious Preoccupation responses reported more anxiety and depression, as well as decreased HRQL.
Tumour site and stage showed no effect on adjustment response. Survival analysis indicated that use of a Helpless-
Hopeless response was related to poorer survival (HR 1.17, p 0.001).
Conclusion: The relation between adjustment responses Helpless-Hopeless and Anxious Preoccupation and
anxiety, depression, HRQL and possibly poorer survival indicate that assessment of mental adjustment should be
considered when planning treatment and rehabilitation in laryngeal cancer patients.
Background
To be diagnosed with laryngeal cancer places consider-
able demand on the patient. Besides the impact of being
diagnosed with a life-threatening disease, patients also
face psychosocial problems due to impairment in voice
and speech and other physical effects caused by treat-
ment [1,2]. As a consequence, laryngeal cancer patients
risk mood disorders such as anxiety and depression, as
well as decreased health-related quality of life (HRQL)
[1,3-5]. Laryngeal cancer patients’ different ratings of
HRQL and psychological well-being have been associated
to both treatment and size of tumour [6]. However, dif-
ferences in HRQL levels and mental well-being may also
be explained by mental coping responses. Over the last
decades, there has been a growing interest in coping and,
particularly, in the area of coping with cancer. The most
widely spread definition of coping is Lazarus’ and Folk-
man’s saying coping can be defined as “constantly chan-
ging cognitive and behavioural efforts to manage specific
external or internal demands that are appraised as taxing
or exceeding the resources of a person” [7]. Related to
Folkman’sa n dL a z a r u s ’ theory of coping is the theory of
mental adjustment to cancer, developed by Watson and
Greer, where mental adjustment is defined as “the cogni-
tive and behavioural responses the patient makes to the
diagnosis of cancer” [8]. Even if the two concepts often
are used synonymously, it is argued that there is one pre-
dominant difference: the theory of mental adjustment
includes emotional reactions to a threatening event,
whereas Folkman and Lazarus regard emotional reactions
as the outcome of a coping strategy. In this paper we
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cancer and, hence, include emotional reactions.
Mental adjustment and coping have been identified as
important factors for HRQL and psychological state in
cancer patients [8-11]. Adjustment responses such as
Fighting Spirit, described as “a highly optimistic attitude,
accompanied by a search for greater information about
[breast] cancer”, have been reported to be beneficial
[12-14], whereas responses like Helpless-Hopeless, when
patients are devoid of hope and see themselves as gravely
ill, have shown a negative impact on HRQL and mental
health [14-17]. Furthermore, there is an ongoing debate
on the possible impact of mental adjustment on the out-
come of cancer, where e.g. Pettingale et al appoint mental
adjustment responses to be the single most significant
factor in determining both death and recurrence [18].
Studies have demonstrated a negative effect of a Help-
less-Hopeless response on five and ten year survival
[19,20], whereas e.g. Fighting Spirit has shown to be ben-
eficial for relapse-free survival [18,21,22]. The connection
between mental adjustment and survival is however a
controversial field and several studies have failed to find
any effect of coping or mental adjustment on survival,
results further supported by a review article by Petticrew
et al [23]. These contradictory findings indicate that the
association between mental adjustment and survival in
cancer patients is still a matter of interest.
There is a growing interest regarding mental adjust-
ment to cancer in patients with head and neck (H&N)
cancer [2,9,24,25], where most studies have indicated an
association between an Avoidance response and
decreased HRQL [25-27], but also an inverse relation
between Fighting Spirit and depression [9]. Due to the
multi-factorial and multi-site nature of H&N cancer
some authors have expressed the need to investigate
adjustment responses in patients with different sites of
H&N cancer [24,28]. Furthermore, there has been a
demand for longitudinal studies on mental adjustment
to cancer [29].
Aim of this study was therefore to investigate longitu-
dinal mental adjustment respo n s e si np a t i e n t st r e a t e d
for laryngeal cancer and the relation to anxiety, depres-
sion, HRQL and survival.
Methods
Participants
Study patients were recruited at a weekly tumour confer-
ence at Sahlgrenska University Hospital to which all
patients with laryngeal cancer in the western part of Swe-
den are admitted. During the study period 210 patients
were admitted to the tumour conference. All eligible
patients were consecutively asked to participate. Of the
147 patients judged as eligible, 47 declined participation
(22 due to not feeling well enough, three due to family
reasons, 22 did not give any reason) while 100 patients
accepted to participate. Of the 63 patients deemed not
eligible reasons for exclusion were: participation in other
studies (19), insufficient knowledge in Swedish language
(10), second primary cancer tumour (9), psychiatric dis-
order (12), dementia (4) and alcohol addiction (9).
All 100 patients included received radiotherapy as part
of their treatment. Chemotherapy was given to 9 patients
with stage III-IV tumours. One patient was laryngecto-
mised before inclusion, two patients were treated with
primary laryngectomy and four patients were treated
with laryngectomy as salvage surgery during the study
year.
Study design
This prospective longitudinal study was ongoing between
1998 and 2005 with a discontinuation for two years. Data
was collected on six occasions: before start of treatment
and at 1, 2, 3, 6 and 12 months after start of treatment.
Results presented in this article are based on data col-
lected with Patient Reported Outcome (PRO) instru-
ments at one month and 12 months after start of
treatment, respectively. These two measurement points
w e r ec h o s e ns i n c et h e yr e p r e s e n tq u i t ed i f f e r e n ts i t u a -
tions. One month into treatment a majority of patients
are approaching the end of their treatment and suffer
from side effects. The experience of receiving the cancer
diagnosis is still fresh in memory and the outcome of the
disease may still be unclear. Eleven months later the
situation is quite different; most patients have recovered
well and received reassuring information about their
health status. A mail-out/mail-back procedure was used
with patients not returning their questionnaires within 2-
3 weeks being reminded once. At the tumour conference,
diagnosis according to TNM (UICC) and ICD, as well as
histopathology, was recorded. Performance status was
rated according to the Karnofsky Performance Scale.
Patients were also asked about previous and present dis-
eases, present symptoms, weight loss and smoking habits.
Socio-demographic data were also recorded.
Two articles based on this material have previously
been published [3,30].
PRO Questionnaires
Mini-MAC
T h eM i n i - M A Ci sar e v i s e dv e r s i o no ft h ew i d e l yu s e d
Mental Adjustment to Cancer scale (MAC) [8], devel-
oped for measuring mental adjustment to cancer in a
general cancer population. The Mini-MAC contains 29
items and the psychometric properties of the Mini-MAC
have proved satisfactory [31]. The Swedish version of the
Mini-MAC has been obtained by standard translation
procedures with forward/backward translation, pre-tested
on different cancer patients and reviewed by clinicians
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on a 4-point Likert scale ranging from “Definitely does
not apply to me” (1) to “Definitely apply to me” (4) and
measures patients experiences at present. The Mini-
MAC has five domains:
￿ Helpless-Hopeless, e.g. “I feel completely at a loss
about what to do” (8 items)
￿ Cognitive Avoidance, e.g. “I distract myself when
thoughts about my illness cme into my head” (4 items)
￿ Fighting Spirit, e.g. “I try to fight the illness” (4 items)
￿ Anxious Preoccupation, e.g. “Iw o r r ya b o u tt h e
cancer returning or getting worse” (8 items)
￿ Fatalism, e.g. “I’ve had a good life; what’sl e f ti sa
bonus” (5 items).
A higher score represents higher endorsement of the
adjustment response. The domains can be scored sepa-
rately through simple addition. Since the domains con-
sist of different number of items we also calculated
mean scores by dividing the sum with number of items.
HAD
The Hospital Anxiety and Depression (HAD) Scale was
developed to detect anxiety and depression in somati-
cally ill patients [32]. The 2-factor structure for anxiety
and depression has been confirmed repeatedly [33,34]
and the Swedish version has been documented in sev-
eral studies [35]. The HAD Scale consists of 14 items
on a four-point response scale ranging from 0-3. The
summary scale scores for anxiety (7 items) and depres-
sion (7 items) thus range from 0-21. For both the anxi-
ety and depression factor we have used the cut off
values recommended by Zigmond and Snaith [32],
where each person is grouped according to a clinically
tested classification of psychiatric morbidity where a
score < 8 is within the normal range, 8-10 indicates a
possible and >10 a probable mood disorder. It has how-
ever been discussed whether there is a need for different
cut off values for different populations [36,37].
EORTC QLQ-C30 and QLQ-H&N35
The European Organisation for Research and Treatment
of Cancer (EORTC) Study Group on Quality of Life has
developed a modular measurement system for evaluating
quality of life in cancer patients [38]. A 30-item core ques-
tionnaire, the EORTC QLQ-C30, assesses the physical and
psychosocial functioning and symptom experiences of
cancer patients in general [39]. To address additional
symptoms associated specifically with H&N cancer and its
treatment a complementary 35-item module can be used,
the QLQ-H&N35 [40,41]. When tested in large, cross-
cultural samples of patients with cancer, both the core
questionnaire and the H&N cancer-specific module have
demonstrated satisfactory to excellent reliability and valid-
ity. Calculated scale scores range from 0-100. On the
different functioning domains and the Global quality of
life a score of 100 corresponds to maximum functioning,
whereas on the symptom domains and separate items a
score of 100 means worst possible symptoms. For analyses
in this paper we used the domains Emotional functioning,
Cognitive functioning, Social functioning, Global QoL and
Pain. Based on previous research and clinical experience
these domains were hypothesized to have the strongest
association to mental adjustment.
Karnofsky performance scale
Karnofsky index is a physician-completed instrument. It
emphasizes physical performance and dependency.
Although not designed as a QoL-measure, it is fre-
quently used as one [42]. The index has 11 descriptions
ranging from 0% (dead) to 100% (normal) [43].
Statistical methods
Descriptive statistics were calculated according to standard
procedures. Wilcoxon’s signed rank test was used for mea-
suring changes over time. Correlations between Mini-Mac
domains and domains measuring anxiety, depression and
HRQL were calculated using Spearman’s correlation. All
tests were two-tailed and conducted at 5% significance
level. Cases of missing data were handled by imputation,
i.e. if less than 50% of items in a domain were missing the
calculated mean value replaced missing items. Number of
false significances was calculated as ((number of tests-
number of significant tests)*alfa)/(1-alfa) [44].
Survival analysis was performed in order to predict
death. Possible prognostic variables used were: age,
tumour stage, tumour site, previous cancer diagnosis,
Karnofsky performance index, family situation and
Mini-MAC subscale Helpless-Hopeless, which was used
as a continuous score. For ordered categorical or contin-
uous variables Cox’sP H - r e g r e s s i o nw a su s e d .H a z a r d
ratios were calculated for descriptive purposes. For mul-
tivariate purposes a stepwise Cox’s PH-regression was
performed. Only variables that affected survival time at
univariate tests (p < 0.1) were included as possible pre-
dictors in the multivariate analysis.
Ethical aspects
The study was conducted in accordance with the
Declaration of Helsinki and was approved by the ethical
committee at Sahlgrenska University Hospital, Gothen-
burg, Sweden.
Results
Participation and compliance
Table 1 contains socio-demographic and clinical charac-
teristics of participants and non-participants. Non-parti-
cipants differed significantly from participants only in a
few aspects: they more often had a supraglottic tumour;
advanced disease and worse performance status
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100 participants 5 did not return their questionnaires at
evaluation one month after start of treatment, producing
ar e s p o n s er a t eo f9 5 % .A t1 2m o n t h sa f t e rs t a r to f
treatment the response rate was 71%. The 29 drop-out
patients missing at 12 months after start of treatment
did not differ from the participants completing the
study regarding gender, age, civil status or educational
level but significantly more were smokers and had a
supraglottic localisation.
Mini-MAC
Missing items were low in numbers and psychometric
properties according to internal consistency and con-
struct validity were acceptable. Cronbach’sa l p h af o r
the five domains are displayed in Table 2. Significant
positive correlations were found between Anxious Pre-
occupation and Helpless-Hopeless (r =0 . 5 8 ) ,F a t a l i s m
and Cognitive Avoidance (r = 0.49) and Fatalism and
Fighting Spirit (r = 0.57), calculated at one month
after start of treatment. Scores for the different adjust-
ment responses at one and 12 months after start of
treatment are displayed in Table 2, together with the
observed change between the two measurement
points. At both measurement points the most fre-
quently used adjustment response was Fighting Spirit
(mean 3.04 and 2.94, respectively), whereas the least
used response was Helpless-Hopeless (1.25 and 1.22,
respectively). Except for Cognitive Avoidance, all
scores decreased during the study but the decrease
was statistically significant only for Anxious Preoccu-
pation and Fatalism.
To investigate the possible effect of tumour site and
stage on mental adjustment patients were grouped into
glottic vs. supra-/sub-/transglottic and stages cis - II vs.
III - IV. No significant differences regarding level of
response were found between patients with different
tumour sites or stages (data not shown).
Table 1 Sociodemographic and clinical characteristics of participants and non-participants
Participants (n = 100) Non-participants (n = 110) p-value
†
Age, mean years (SD) 67 (11.4) 69 (10.11) ns
Sex ns
Female 17 (17%) 22 (20%)
Male 83 (83%) 88 (80%)
Tumour site
Glottic 72 (72%) 61 (55%) 0.0188
Supraglottic 20 (20%) 37 (34%) 0.0382
Subglottic 4 (4%) 3 (3%) ns
Transglottic 4 (4%) 9 (8%) ns
Stage
0 3 (3%) 2 (2%)
I 57 (57%) 43 (39%)
II 22 (22%) 24 (22%)
III 9 (9%) 17 (15%)
IV 9 (9%) 24 (22%) 0.001
Karnofsky performance scale
100 60 (63%) 34 (33%)
90 23 (24%) 33 (31%)
80 8 (8%) 20 (19%)
70 3 (3%) 12 (11%)
60 0 (0%) 1 (1%)
50 1 (1%) 1 (1%)
40 0 (0%) 4 (4%) >0.001
Married/Cohabitant 70 (70%) 62 (56%) ns
Smokers 50 (50%) 70 (64%) ns
Loss of weight 21 (21%) 35 (32%) ns
Residual disease 2 (2%) 2 (2%) ns
Cardiovascular disease 45 (45%) 38 (35%) ns
Other malignancy 8 (8%) 11 (10%) ns
†p-value significant at ≤0.05, ns = not significant.
Participants were classified as N0M0, except one patient classified as N2M0 and two classified as N2M1. Among non-participants 10 patients were classified as
N1M0, six as N2M0, one as N3M0 and one patient as N2M1.
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depression and HRQL
Correlations between the Mini-MAC and pre-specified
domains from the HAD, EORTC, and age are displayed
in Table 3. The highest correlations at both measure-
ment points were found between the Anxious Preoccu-
pation and Helpless-Hopeless responses and Anxiety,
Depression and Emotional Functioning. Although
weaker, significant correlations were also found between
these adjustment responses and other EORTC domains.
Furthermore, when analysing adjustment response by
HAD subgroups, results showed that patients with prob-
able or possible mood disorders reported significantly
increased scores for Helpless-Hopeless and Anxious Pre-
occupation responses (data not shown). For the Cogni-
tive Avoidance, Fatalism and Fighting Spirit responses
only weak or no correlations were found.
Survival analysis
For survival analyses patients were followed up via med-
ical journals and the Swedish national registration. Med-
ian time for follow up was 4.22 years from inclusion
(inter-quartile-range 2.34 - 7.58 years). During this per-
iod 36 patients passed away. No patient was lost to fol-
low-up. Table 4 contains the results of the univariate
survival analysis and Table 5 the results of the multi-
variate survival analysis. The results indicate that the
risk of death in patients with high scores on the Mini-
MAC Helpless-Hopeless scale was slightly increased.
Remaining scales of the Mini-MAC showed no signifi-
cant effect on survival. There was no evidence of an
increasing or decreasing trend over time in the Hazard
ratio.
Discussion
Using a longitudinal design, aim of this study was to
investigate the relation between mental adjustment to
cancer and anxiety, depression, HRQL, and survival in
patients treated for laryngeal cancer. At both measure-
ment points a higher score on the Helpless-Hopeless
and Anxious Preoccupation domain was associated with
anxiety, depression and decreased HRQL. These findings
are in line with what has previously been demonstrated
in other cancer diagnoses [14,17]. Tumour site and
stage showed no effect on adjustment response. How-
ever, survival analysis suggested a slightly increased risk
of death for patients using a Helpless-Hopeless
response. Data presented in this article was gathered at
two occasions and the measurement points were chosen
because they represent quite different situations. At one
month after start of treatment a majority of patients are
at the end of their treatment and many suffer from side
effects. Furthermore, the experience of receiving the
cancer diagnosis is fresh in memory and the outcome of
the disease might still be unclear. Eleven months later
the situation is quite different; most patients have recov-
ered well and received reassuring information about
their health status. According to Lazarus’ and Folkman’s
transactional theory [7] the use of coping is motivated
by how we cognitively appraise a situation and it could
b ea s s u m e dt h a tt h e s ep a t i e n t sw o u l da p p r a i s et h e i r
situation as less stressful at the latter measurement
point. Hence, it could be expected that the pattern of
adjustment responses should change over time with, in
particular, a decreased use of both Anxious Preoccupa-
tion and Helpless-Hopeless responses. However, of the
two, only Anxious Preoccupation obtained statistical
Table 2 Mean values, SD and range of scores for Mini-MAC domains one month and 12 months after start of
treatment
Baseline Follow-up Change Baseline
Mean (SD) Range Mean (SD) Range p-value
† Cronbach’s alpha
AP total* 14.15 (5.09) 8-29 12.28 (4.07) 8-26 0.01 0.85
AP mean** 1.77 (0.64) 1-3.63 1.54 (0.51) 1-3.25
CA total* 10.52 (3.34) 4-16 10.94 (3.07) 4-16 ns 0.74
CA mean** 2.63 (0.84) 1-4 2.74 (0.77) 1-4
FA total* 13.53 (2.99) 5-20 12.87 (3.09) 7-20 0.01 0.61
FA mean** 2.71 (0.60) 1-4 2.57 (0.62) 1.4-4
FS total* 12.15 (2.58) 4-16 11.76 (2.57) 7-16 ns 0.50
FS mean** 3.04 (0.64) 1-4 2.94 (0.64) 1.75-4
HH total* 9.97 (3.19) 8-28 9.76 (3.56) 8-5 ns 0.81
HH mean** 1.25 (0.40) 1-3.5 1.22 (0.44) 1-3.13
AP = Anxious Preoccupation, CA = Cognitive Avoidance, FA = Fatalism, FS = Fighting Spirit, HH = Helpless-Hopeless.
*Min-Max scores of AP 8-32; CA 4-16; FA 5-20; FS 4-16;HH 8-32.
**Min-Max 1-4 (mean computed by dividing total sum with number of items).
† p-value significant at ≤0.05.
ns = not significant, Wilcoxon’s signed rank test.
Number of false significances is calculated to 0.16.
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Fighting Spirit and Cognitive Avoidance, remained
stable. This impression of stability has previously been
demonstrated by Nordin et al [15] and it can be argued
that it reflects an aspect of personality [15,45] or life
experience given the homogeneity in age and gender for
this group. Regarding the Helpless-Hopeless response,
the tendency for a floor effect could also leave little
room for improvement. A statistically significant
decrease was seen for the Fatalism dimension, as pre-
viously described also in patients with gastrointestinal
cancer [15].
Since the transactional theory of coping emphasizes
the importance of the context, one could expect more
severe stressors, such as more advanced disease, to be
associated with more extensive coping efforts or adjust-
ment responses. This has been indicated by previous
research, e.g. Epping-Jordan et al, who showed more
advanced stages of breast cancer to be connected to
greater use of disengagement coping strategies [46]. In
our material however, no significant differences regard-
ing level of response were found between patients with
different tumour sites or stages. This lack of association
could be due to the fact that a majority of participants
had glottic tumours and less advanced tumour stages.
Table 3 Mini-MAC correlations with HADS, EORTC QLQ-C30, EORTC QLQ-H&N35 and age, one month and 12 months
after start of treatment
Anxious Preoccupation Cognitive Avoidance Fatalism Fighting Spirit Helpless-Hopeless
HAD - Anxiety
1 month 0.66 (<0.0001) -0.11 -0.12 -0.17 0.50 (<0.0001)
12 months 0.59 (<0.0001) -0.16 -0.11 -0.36 (0.002) 0.58 (<0.0001)
HAD-Depression
1 month 0.56 (<0.0001) -0.32 -0.09 -0.14 0.52 (<0.0001)
12 months 0.58 (<0.0001) -0.14 -0.06 -0.20 0.62 (<0.0001)
EORTC QLQ-C30
Emotional functioning
1 month -0.63 (<0.0001) 0.02 0.02 0.11 -0.46 (<0.0001)
12 months -0.52 (<0.0001) 0.10 0.14 0.31 (0.008) -0.49 (<0.0001)
Cognitive functioning
1 month -0.39 (<0.0001) 0.01 0.13 0.13 -0.34 (0.0007)
12 months -0.45 (<0.0001) 0.06 0.16 0.35 (0.003) -0.30 (0.01)
Social functioning
1 month -0.36 (0.0003) 0.09 0.02 -0.03 -0.34 (0.0007)
12 months -0.44 (0.0001) 0.17 0.18 -0.08 -0.33 (0.004)
Global QoL
1 month -0.39 (<0.0001) -0.035 -0.03 -0.03 -0.30 (0.003)
12 months -0.56 (<0.0001) -0.12 0.15 -0.37 (0.002) -0.53 (<0.0001)
Pain
1 month 0.41 (<0.0001) -0.06 0.13 0.08 0.36 (0.0004)
12 months 0.28 (0.018) -0.15 -0.03 -0.15 0.24 (0.039)
Spearman correlation coefficients (significant p-value).
Number of false significances is calculated to 2.
Table 4 Univariate survival analysis
Variable Hazard Ratio
(95% CI)
Cox
p-value
Age 1.049 (1.013-1.086) 0.007
Stage
cis+I+II vs. III+IV 2.082 (1.008-4.301) 0.048
Family situation
married/cohabitant vs.
others
0.501 (0.262-0.957) 0.036
Tumour site
Glottic vs. others 0.315 (0.166-0.597) <0.001
Karnofsky Performance scale 0.949 (0.921-0.977) 0.001
Previous cancer diagnosis 2.727 (1.060-7.013) 0.037
Mini-MAC - Helpless-Hopeless 1.168 (1.067-1.279) 0.001
Number of false significances is calculated to 0.
Table 5 Multivariate survival analysis
Variable Hazard Ratio (95% CI)
Age 1.065 (1.02-1.11)
Stage
cis+I+II vs. III+IV 1.149 (0.44-3.00)
Tumour site
glottic vs. others 0.315 (0.13-0.74)
Mini-MAC-Helpless-Hopeless 1.234 (1.12-1.36)
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Preoccupation and Helpless-Hopeless and both anxiety
and depression are in line with findings in previous stu-
dies [15,17,31]. The relation between these adjustment
responses and psychiatric morbidity was even more
transparent when analysis demonstrated that the use of
both Helpless-Hopeless and Anxious Preoccupation was
significantly more common among patients with a possi-
ble/probable mood disorder. This relation seems to be
stable over time; results of correlation analyses at one
and 12 months are more or less unchanged, demon-
strating that a Helpless-Hopeless or an Anxious Preoc-
cupation response has a negative impact on well-being,
irrespective of phase of illness.
Anxious Preoccupation and Helpless-Hopeless were
also associated with pain, a finding previously demon-
strated by Okano et al [47]. The causal relation is not
evident - does untreated pain increase patients’ use of
maladaptive adjustment responses or does the use of
these adjustment responses make patients more sensitive
to pain? In either case, it could indicate the importance
of proper analgesic treatment and the possibility to
reduce the sensation of pain if the use of maladaptive
adjustment responses could be modified.
Fighting Spirit is frequently claimed to have a benefi-
cial effect on psychiatric morbidity [14,48]. Although
being the most frequently reported adjustment response
by our patients, we found no significant correlation
between Fighting Spirit and mood disorders at the first
measurement point, a finding also demonstrated by e.g.
Grassi et al [17]. However, at follow-up 12 months after
start of treatment a higher score on the Fighting Spirit
subscale was associated to lower levels of anxiety. This
could indicate that a Fighting Spirit response may facili-
tate the ability to move on with life beyond the cancer.
A seemingly illogical finding was the negative correla-
tion between Fighting Spirit and Global Quality of life
at 12 months. It should however be noted that Global
Quality of life measured by the EORTC QLQ-C30 con-
sists of one single item, hence not a very robust con-
struct. The association could possibly also be due to the
relatively low reliability of the Fighting Spirit domain.
Also in the Norwegian, Korean and Greek versions of
the Mini-MAC, Fighting Spirit has produced lower
internal consistency than the other domains [49-51].
This may indicate that Mini-MAC’s Fighting Spirit
domain can include items not actually measuring this
concept or that, due to cultural differences, some items
are perceived as irrelevant by patients or hard to
interpret.
Several studies have shown a relation between avoid-
ance and poorer HRQL in patients with H&N cancer
[25,27,29]. However, we found no such associations but
instead that Cognitive Avoidance at one month after
treatment start may have a positive effect (not signifi-
cant) on depression. It has been argued that the effect
of an avoidant adjustment response, predominately dur-
ing the most stressful period with diagnosis and treat-
ment, can be beneficial [21]. Furthermore, there seems
to be cultural differences regarding the outcome of an
avoidant adjustment response. In the Chinese, Korean as
well as the Greek and Italian versions of the Mini-MAC,
Cognitive Avoidance is considered to be part of good
adjustment [49,50,52,53], while in the Norwegian and
English versions Cognitive A v o i d a n c ea p p e a r st ob ea n
indicator for poor adjustment [31,51].
The effect of coping and mental adjustment on survi-
val in cancer patients has been heavily debated during
the last decades. Although some studies have found a
beneficial effect of a Fighting Spirit response [21,54],
some authors have argued that the lack of such findings
may be comforting to patients who can not maintain a
fighting spirit or a positive attitude [20]. Despite the
exclusion of patients with a more advanced disease and
lower performance status we found a tendency for the
Helpless-Hopeless response to have an adverse impact
on survival, results that are in line with Watson et al
[19,20]. These findings should however be interpreted
with caution due to the relatively small size. One possi-
ble explanation for the association between mental
adjustment and survival may be that a Helpless-Hope-
less response could result in behavioural changes leading
to ineffective treatment, e.g. a passive behaviour with
failing to come to follow-up visits or neglecting symp-
toms of recurrence [20,55]. Other possible explanations
proposed have been immunological or hormonal [56].
The assessment of mental adjustment has been advo-
cated by several authors, e.g. Matsushita et al, who
stress the importance of focussing on patient’s individual
adjustment styles in order to recognize the specific care
needed [10]. It could, therefore, be argued that screening
of all laryngeal cancer patients are justified to identify
those with maladaptive adjustment responses in order to
provide e.g. psychotherapy that may improve adjustment
responses [57,58] and possibly even prolong survival
[59,60]. Other patients may need more information
about their disease or how to get in touch with patient
support organisations.
Any instrument used for assessment need to be valid
and reliable. A prerequisite for this in PRO instruments
is patient input regarding what are relevant items and
how they are expressed. Contrary to many other existing
PROs the original version of the MAC is based on a
great number of patient interviews. However, psycho-
metric evaluations in different languages of the Mini-
MAC have demonstrated that the original five factor
structure may need to be revised [49-51]. Even though
our confirmatory analysis demonstrated agreement with
Johansson et al. BMC Cancer 2011, 11:283
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Page 7 of 9the original five factor solution we found some deviating
item loadings.
Limitations
There were some shortcomings of this study. Firstly, the
sample size is quite small. However, laryngeal cancer is
a rather uncommon diagnosis, with approximately 200
new cases per year and this is to our knowledge the lar-
gest Scandinavian longitudinal study made on mental
adjustment and HRQL in patients treated for laryngeal
cancer. Another shortcoming might be that excluded
patients had a more advanced disease and lower perfor-
mance status than those included, with a possible
underestimation of the prevalence of psychiatric mor-
bidity and use of maladaptive mental adjustment
responses. Furthermore, when translating a PRO, a cul-
tural adaptation is also needed to confirm if patients
find items to be relevant and intelligible. The Swedish
version of the Mini-MAC was evaluated by a group of
patients; however, a full-scale cognitive debriefing was
never performed. Therefore, to further investigate the
content validity of the Mini-MAC in the Swedish laryn-
geal cancer population, we are currently performing an
interview study.
Conclusions
This study aimed to investigate the relation between
mental adjustment to cancer,a n x i e t y ,d e p r e s s i o na n d
HRQL in laryngeal cancer patients. The findings confirm
results previously demonstrated in diverse cancer popula-
tions: positive correlations between adjustment responses
Helpless-Hopeless and Anxious Preoccupation and anxi-
ety and depression, negative associations with HRQL and
a possible relation to poorer survival. This indicates that
assessments of mental adjustment should be considered
when planning treatment and rehabilitation in patients
with laryngeal cancer. Our results also raise the question
of a need for further investigating the content validity of
the Swedish version of the Mini-MAC Scale. Strengths of
this study are its longitudinal design, as well as the focus
on patients with laryngeal cancer in which research on
mental adjustment and coping has been scarce.
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